Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-030028
Filing Date
2010-03-30
Accepted
2010-03-30 16:30:40
Documents
12
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c98259e10vk.htm 10-K 791047
2 EXHIBIT 4.9 c98259exv4w9.htm EX-4.9 58422
3 EXHIBIT 10.12 c98259exv10w12.htm EX-10.12 7501
4 EXHIBIT 10.22 c98259exv10w22.htm EX-10.22 15388
5 EXHIBIT 10.23 c98259exv10w23.htm EX-10.23 13326
6 EXHIBIT 10.39 c98259exv10w39.htm EX-10.39 5324
7 EXHIBIT 23.1 c98259exv23w1.htm EX-23.1 1539
8 EXHIBIT 31.1 c98259exv31w1.htm EX-31.1 9085
9 EXHIBIT 31.2 c98259exv31w2.htm EX-31.2 9053
10 EXHIBIT 32.1 c98259exv32w1.htm EX-32.1 3387
11 EXHIBIT 32.2 c98259exv32w2.htm EX-32.2 3429
12 GRAPHIC c98259p9825901.jpg GRAPHIC 150283
  Complete submission text file 0000950123-10-030028.txt   1126241
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31812 | Film No.: 10714223
SIC: 2836 Biological Products, (No Diagnostic Substances)